Hypoparathyroidism medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Hypoparathyroidism}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{..." |
No edit summary |
||
| Line 3: | Line 3: | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | |||
==Treatment== | |||
Severe hypocalcemia, a potentially life-threatening condition, is treated as soon as possible with [[intravenous]] [[calcium]] (e.g. as [[calcium gluconate]]). Generally, a central venous catheter is recommended, as the calcium can irritate [[peripheral vein]]s and cause [[phlebitis]]. | |||
Long-term treatment of hypoparathyroidism is with calcium and [[Vitamin D3]] supplementation (D1 is ineffective in the absence of renal conversion). [[Teriparatide]], a synthetic form of PTH (presently registered for [[osteoporosis]]) might become the treatment of choice for PTH supplementation, although further studies are awaited. | |||
==References== | ==References== | ||
Revision as of 21:45, 20 September 2012
|
Hypoparathyroidism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoparathyroidism medical therapy On the Web |
|
American Roentgen Ray Society Images of Hypoparathyroidism medical therapy |
|
Risk calculators and risk factors for Hypoparathyroidism medical therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Treatment
Severe hypocalcemia, a potentially life-threatening condition, is treated as soon as possible with intravenous calcium (e.g. as calcium gluconate). Generally, a central venous catheter is recommended, as the calcium can irritate peripheral veins and cause phlebitis.
Long-term treatment of hypoparathyroidism is with calcium and Vitamin D3 supplementation (D1 is ineffective in the absence of renal conversion). Teriparatide, a synthetic form of PTH (presently registered for osteoporosis) might become the treatment of choice for PTH supplementation, although further studies are awaited.